Your browser doesn't support javascript.
loading
Anatomy of a superenhancer.
Kim, Sunkyung; Liu, Tian-Tian; Ou, Feiya; Murphy, Theresa L; Murphy, Kenneth M.
Afiliación
  • Kim S; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, United States. Electronic address: sunkyung.kim@wustl.edu.
  • Liu TT; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, United States.
  • Ou F; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, United States.
  • Murphy TL; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, United States.
  • Murphy KM; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, United States. Electronic address: kmurphy@wustl.edu.
Adv Immunol ; 163: 51-96, 2024.
Article en En | MEDLINE | ID: mdl-39271259
ABSTRACT
Interferon regulatory factor-8 (IRF8) is the lineage determining transcription factor for the type one classical dendritic cell (cDC1) subset, a terminal selector for plasmacytoid dendritic cells and important for the function of monocytes. Studies of Irf8 gene regulation have identified several enhancers controlling its activity during development of progenitors in the bone marrow that precisely regulate expression at distinct developmental stages. Each enhancer responds to distinct transcription factors that are expressed at each stage. IRF8 is first expressed in early progenitors that form the monocyte dendritic cell progenitor (MDP) in response to induction of the transcription factor CCAAT/enhancer-binding protein alpha (C/EBPα) acting at the Irf8 +56 kb enhancer. IRF8 levels increase further as the MDP transits into the common dendritic cell progenitor (CDP) in response to E protein activity at the Irf8 +41 kb enhancer. Upon Nfil3-induction in CDPs leading to specification of the cDC1 progenitor, abrupt induction of BATF3 forms the JUN/BATF3/IRF8 heterotrimer that activates the Irf8 +32 kb enhancer that sustains Irf8 autoactivation throughout the cDC1 lifetime. Deletions of each of these enhancers has revealed their stage dependent activation. Surprisingly, studies of compound heterozygotes for each combination of enhancer deletions revealed that activation of each subsequent enhancer requires the successful activation of the previous enhancer in strictly cis-dependent mechanism. Successful progression of enhancer activation is finely tuned to alter the functional accessibility of subsequent enhancers to factors active in the next stage of development. The molecular basis for these phenomenon is still obscure but could have implications for genomic regulation in a broader developmental context.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Dendríticas / Elementos de Facilitación Genéticos / Factores Reguladores del Interferón Límite: Animals / Humans Idioma: En Revista: Adv Immunol Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Dendríticas / Elementos de Facilitación Genéticos / Factores Reguladores del Interferón Límite: Animals / Humans Idioma: En Revista: Adv Immunol Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos